首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
pruritus cutaneous benign tumor相关文献:
Immune checkpoint inhibitor-related dermatologic adverse events.
Geisler AN, Phillips GS, Barrios DM, Wu J, Leung DYM, Moy AP, Kern JA, Lacouture ME.
J Am Acad Dermatol. 2020 Nov;83(5):1255-1268. doi: 10.1016/j.jaad.2020.03.132. Epub 2020 May 23.
PMID:32454097
Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance.
Bhardwaj M, Chiu MN, Pilkhwal Sah S.
Cutan Ocul Toxicol. 2022 Mar;41(1):73-90. doi: 10.1080/15569527.2022.2034842. Epub 2022 Feb 20.
PMID:35107396
What Is New in Cutaneous T Cell Lymphoma?
Morgenroth S, Roggo A, Pawlik L, Dummer R, Ramelyte E.
Curr Oncol Rep. 2023 Nov;25(11):1397-1408. doi: 10.1007/s11912-023-01464-8. Epub 2023 Oct 24.
PMID:37874473
Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features.
Ellis SR, Vierra AT, Millsop JW, Lacouture ME, Kiuru M.
J Am Acad Dermatol. 2020 Oct;83(4):1130-1143. doi: 10.1016/j.jaad.2020.04.105. Epub 2020 Apr 29.
PMID:32360716
Pruritus in Cutaneous T-Cell Lymphoma and Its Management.
Serrano L, Martinez-Escala ME, Zhou XA, Guitart J.
Dermatol Clin. 2018 Jul;36(3):245-258. doi: 10.1016/j.det.2018.02.011.
PMID:29929596
What's New in Cutaneous T-Cell Lymphoma-Associated Pruritus.
Biazus Soares G, Guitart J, Yosipovitch G.
Am J Clin Dermatol. 2024 Jan;25(1):67-77. doi: 10.1007/s40257-023-00823-2. Epub 2023 Nov 16.
PMID:37971624
Care of Congenital Melanocytic Nevi in Newborns and Infants: Review and Management Recommendations.
Jahnke MN, O'Haver J, Gupta D, Hawryluk EB, Finelt N, Kruse L, Jen M, Horii KA, Frieden IJ, Price H, Coughlin CC.
Pediatrics. 2021 Dec 1;148(6):e2021051536. doi: 10.1542/peds.2021-051536.
PMID:34845496
Malignancy-associated pruritus.
Rowe B, Yosipovitch G.
Eur J Pain. 2016 Jan;20(1):19-23. doi: 10.1002/ejp.760. Epub 2015 Sep 28.
PMID:26416212
Mechanisms and treatments of neuropathic itch in a mouse model of lymphoma.
Chen O, He Q, Han Q, Furutani K, Gu Y, Olexa M, Ji RR.
J Clin Invest. 2023 Feb 15;133(4):e160807. doi: 10.1172/JCI160807.
PMID:36520531
Dermatologic toxicities to inhibitors of cyclin-dependent kinases CDK 4 and 6: An updated review for clinical practice.
Sibaud V, Sollena P.
Ann Dermatol Venereol. 2023 Sep;150(3):208-212. doi: 10.1016/j.annder.2022.11.013. Epub 2023 Aug 14.
PMID:37586898
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3